{"id":"W4417019670","doi":"10.1182/blood-2025-4588","title":"Real world efficacy and safety of elranatamab, a BCMA bispecific antibody for patients with relapsed and refractory multiple myeloma: An international myeloma working group immunotherapy database analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Multiple myeloma; Refractory (planetary science); Immunotherapy; Progression-free survival; Progressive disease; Hematology; Phases of clinical research; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003004693,0.0002045982,0.000953187,0.001801519,0.0002245776,0.001126444,0.0005636498,0.000401903,0.001497597],"category_scores_gemma":[0.004919536,0.0001779266,0.0008948083,0.003716994,0.0001664871,0.0006373164,0.000481796,0.000371531,0.0003395726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006998195,"about_ca_system_score_gemma":0.0008955883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001888559,"about_ca_topic_score_gemma":0.002450418,"domain_scores_codex":[0.9972509,0.0007743968,0.0008259716,0.000483117,0.0005392809,0.0001263678],"domain_scores_gemma":[0.9936857,0.001650589,0.003384371,0.0004750825,0.0005353131,0.0002689606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006821279,0.0002009242,0.9651175,0.0009383696,0.002441118,0.0002383968,0.0001101827,0.0006551598,0.0006721938,0.0001685306,0.002816716,0.01981967],"study_design_scores_gemma":[0.0008694865,0.0009307549,0.9845229,0.0002106885,0.002332418,0.0009752355,0.000162963,0.00137036,0.0006328995,0.0001042758,0.007860042,0.00002795622],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9346963,0.0054379,0.0008166995,0.0001993663,0.00001189836,0.0003826919,0.05598585,0.00002322027,0.002446151],"genre_scores_gemma":[0.9409099,0.001436132,0.0009524396,0.0001613673,0.00002478398,0.0004803805,0.05573053,0.00001082352,0.0002935584],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003004693,"threshold_uncertainty_score":0.01589054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01603897765478341,"score_gpt":0.3084764834002524,"score_spread":0.292437505745469,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}